How does the drug interact with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml:
Co-administration of BCG vaccine with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml may reduce the effect of BCG vaccine.
How to manage the interaction:
If you are about to receive BCG vaccine, inform the doctor that you are taking Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml. Do not discontinue the medication without consulting a doctor.
How does the drug interact with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml:
Co-administration of methotrexate with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml can increase the levels and side effects of methotrexate.
How to manage the interaction:
Although there is a possible interaction between methotrexate and Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml, you can take these medicines together if prescribed by your doctor. However, if you experience any symptoms such as tiredness, dizziness, fainting, unusual bleeding or bruising, chills, fever, sore throat, body pains. Consult a doctor immediately. Do not stop using medications without a doctor's advice.
How does the drug interact with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml:
Co-administration of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml with doxycycline may reduce the therapeutic effect of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml.
How to manage the interaction:
Although there is a possible interaction between Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml and Doxycycline, you can take these medicines together if prescribed by your doctor. Do not stop using any medications without consulting a doctor.
How does the drug interact with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml:
Co-administration of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml and Cholera, live attenuated may reduce the activity of the vaccine.
How to manage the interaction:
If you are currently being treated with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml or have been treated within the last 14 days, talk to your doctor before receiving cholera vaccine, live. Do not discontinue the medication without consulting a doctor.
How does the drug interact with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml:
Co-administration of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml and Zalcitabine can be decreased when combined with Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml.
How to manage the interaction:
There may be a possibility of interaction between Zalcitabine and Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml, but it can be taken if prescribed by a doctor. Do not discontinue any medications without consulting a doctor.